###begin article-title 0
Diseased muscles that lack dystrophin or laminin-alpha2 have altered compositions and proliferation of mononuclear cell populations
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Multiple types of mononucleate cells reside among the multinucleate myofibers in skeletal muscles and these mononucleate cells function in muscle maintenance and repair. How neuromuscular disease might affect different types of muscle mononucleate cells had not been determined. In this study, therefore, we examined how two neuromuscular diseases, dystrophin-deficiency and laminin-alpha2-deficiency, altered the proliferation and composition of different subsets of muscle-derived mononucleate cells.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 248 252 248 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 278 283 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 283 287 283 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 520 528 516 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 178 183 <span type="species:ncbi:10090">mouse</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
We used fluorescence-activated cell sorting combined with bromodeoxyuridine labeling to examine proliferation rates and compositions of mononuclear cells in diseased and healthy mouse skeletal muscle. We prepared mononucleate cells from muscles of mdx (dystrophin-deficient) or Lama2-/- (laminin-alpha2-deficient) mice and compared them to cells from healthy control muscles. We enumerated subsets of resident muscle cells based on Sca-1 and CD45 expression patterns and determined the proliferation of each cell subset in vivo by BrdU incorporation.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 186 190 182 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 194 199 190 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 199 203 195 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 255 257 251 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 392 396 388 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 413 418 409 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 418 422 414 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 497 498 493 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 503 505 499 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 583 587 579 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 625 630 621 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 630 634 626 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
We found that the proliferation and composition of the mononucleate cells in dystrophin-deficient and laminin-alpha2-deficient diseased muscles are different than in healthy muscle. The mdx and Lama2-/- muscles showed similar significant increases in CD45+ cells compared to healthy muscle. Changes in proliferation, however, differed between the two diseases with proliferation increased in mdx and decreased in Lama2-/- muscles compared to healthy muscles. In particular, the most abundant Sca-1-/CD45- subset, which contains muscle precursor cells, had increased proliferation in mdx muscle but decreased proliferation in Lama2-/- muscles.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
The similar increases in CD45+ cells, but opposite changes in proliferation of muscle precursor cells, may underlie aspects of the distinct pathologies in the two diseases.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 583 584 583 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 585 586 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 749 754 745 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 754 757 750 753 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 785 788 781 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx</italic>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
In diseased skeletal muscle, damaged myofibers can sometimes be replaced or repaired by mononucleate muscle precursor cells that can commit to myogenesis and fuse to form multinucleate myofibers. In some muscle diseases, progressive loss of muscle function may be due at least in part to a decreasing rate of repair that becomes insufficient to replace lost myofibers. The mononucleate cells in skeletal muscle include the relatively abundant muscle satellite cells and their myoblast progeny, as well as infiltrating inflammatory cells and the much less numerous muscle stem cells [1-4]. In this study, we examine how different subsets of muscle-derived mononucleate cells are affected in the diseased skeletal muscles of laminin-alpha2-deficient (Lama2-/-) and dystrophin-deficient (mdx) mice. We examined these two diseases because both the extracellular laminin-alpha2 and the intracellular dystrophin proteins interact with the dystroglycan complex of membrane proteins, yet the pathologies of the two diseases are significantly different.
###end p 11
###begin p 12
###xml 52 58 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2 </italic>
###xml 177 178 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 179 180 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 324 325 316 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 326 327 318 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 330 335 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 335 339 327 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 470 471 458 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 472 474 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 549 551 537 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 552 554 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 339 343 <span type="species:ncbi:10090">mice</span>
###xml 383 388 <span type="species:ncbi:9606">human</span>
Mice lacking laminin-alpha2 due to mutations in the Lama2 gene have greatly shortened lifespan, poor muscle growth, and poor muscle regeneration compared to normal littermates [5,6]. Laminin-alpha2 is a subunit of the basement membrane component known as merosin (or laminin 2/4) and is highly expressed in skeletal muscle [7,8]. Lama2-/- mice are a model for the severely disabling human disease, primary laminin-alpha2-deficient Congenital Muscular Dystrophy Type 1A [9,10], which is also known as merosin-deficient congenital muscular dystrophy [11,12].
###end p 12
###begin p 13
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 242 247 242 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 373 375 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 150 154 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 382 387 <span type="species:ncbi:9606">human</span>
The mdx mice carry a point mutation in the dystrophin gene that leads to loss of functional dystrophin protein. Muscle pathology in 2-4 month old mdx mice is characterized by widespread muscle fiber degeneration and regeneration [13]. Unlike Lama2-null mice, mdx mice have almost normal life spans and their muscles show evidence of continuing, successful regeneration [14,15]. The human disease, Duchenne muscular dystrophy, is also caused by mutations in the dystrophin gene.
###end p 13
###begin p 14
###xml 152 153 152 153 <underline xmlns:xlink="http://www.w3.org/1999/xlink">S</underline>
###xml 157 158 157 158 <underline xmlns:xlink="http://www.w3.org/1999/xlink">c</underline>
###xml 162 163 162 163 <underline xmlns:xlink="http://www.w3.org/1999/xlink">a</underline>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 490 491 490 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 750 751 750 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 763 764 763 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 769 771 769 771 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 951 953 947 949 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 954 956 950 952 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 968 969 964 965 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 974 976 970 972 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1039 1041 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
For this study, we classified mononucleate cells derived from skeletal muscles based on expression of two cell surface proteins: Sca-1 and CD45. Sca-1 (Stem cell antigen 1) was first described as a hematopoietic stem cell marker [16] and subsequently found to be expressed by a rare subset of the mononucleate cells in skeletal muscles [17-19]. CD45 is a cell surface tyrosine phosphatase found on all nucleated cells of hematopoietic origin and is also found on rare muscle-derived cells [1]. The expression patterns of these two proteins define four subsets of cells. The double-negative subset includes muscle satellite cells and their myoblast progeny [20]. The double-positive subset includes cells that appear to be multi-potential stem cells [1]. The Sca-1-/CD45+ subset includes infiltrating inflammatory cells; and different subsets of this heterogeneous group of cells are found in dystrophin-deficient and laminin-alpha2-deficient muscles [21-27]. The Sca-1+/CD45- subset includes cells with myogenic and endothelial potential [28].
###end p 14
###begin p 15
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 164 169 164 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 169 173 169 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 301 303 301 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 330 331 330 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 332 333 332 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 726 730 722 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 734 739 730 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 739 742 735 738 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 789 791 785 787 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 884 888 880 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 896 904 892 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 989 994 985 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 994 998 990 994 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 830 834 <span type="species:ncbi:10090">mice</span>
Previous studies suggested that satellite cells and their myoblast progeny have higher than normal proliferation in mdx muscles [15,31], but proliferation rates in Lama2-/- muscles had not been well studied. In addition, it was known that injury induced by cardiotoxin leads to an increase in the CD45+ cells in skeletal muscles [3,4]. No previous studies, however, had examined how dystrophin-deficiency and laminin-alpha2-deficiency might alter the proliferation and composition of different subsets of muscle-derived mononucleate cells. In this study, therefore, we examined proliferation rates and compositions of the Sca-1 and CD45 defined subsets of skeletal muscle cells. Our results show that dystrophic muscles (both mdx and Lama2-/-) have a similarly increased percentage of CD45+ cells compared to muscles of wild-type mice. Furthermore, we found that most cell subsets in mdx muscles in vivo had increased proliferation relative to normal muscles, whereas most cell subsets in Lama2-/- muscles had lower than normal proliferation. The contrasting proliferation profiles of the different subsets of mononucleate cells in dystrophin-deficient and laminin-alpha2-deficient muscles may explain aspects of the distinct pathologies of the two diseases.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice, breeding, and genotyping
###end title 17
###begin p 18
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dmd</italic>
###xml 70 73 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx</italic>
###xml 70 73 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>mdx</italic></sup>
###xml 86 89 86 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx</italic>
###xml 330 336 326 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2 </italic>
###xml 371 372 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 373 375 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 409 414 401 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dy-W </italic>
###xml 415 416 407 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 432 437 424 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 437 439 429 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dy</italic>
###xml 440 441 432 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">W</italic>
###xml 437 444 429 436 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>dy</italic>-<italic>W</italic>/+ </sup>
###xml 616 622 604 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2 </italic>
###xml 622 625 610 613 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 661 666 649 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 666 669 654 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 683 688 671 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 688 691 676 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 752 757 740 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 757 759 745 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dy</italic>
###xml 760 762 748 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">W </italic>
###xml 757 762 745 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>dy</italic>-<italic>W </italic></sup>
###xml 861 862 849 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 920 925 908 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 925 929 913 917 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 942 946 930 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama</italic>
###xml 946 949 934 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2dy</italic>
###xml 950 951 938 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">W</italic>
###xml 952 954 940 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dy</italic>
###xml 955 957 943 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink">W </italic>
###xml 946 957 934 945 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>2dy</italic>-<italic>W</italic>/<italic>dy</italic>-<italic>W </italic></sup>
###xml 1053 1054 1037 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1150 1152 1134 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 267 271 <span type="species:ncbi:10090">mice</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
###xml 1122 1126 <span type="species:ncbi:10090">mice</span>
For dystrophin-deficient muscles, we used mice of the C57BL/10ScSn-Dmdmdx/J genotype (mdx); and as a normal muscle control for the dystrophin-deficient mice, we used C57BL/10ScSn mice (Jackson Laboratory, Bar Harbor ME). For laminin-alpha2-deficient muscles, we used mice that carry a targeted LacZ insertion that inactivates the Lama2 gene which encodes laminin-alpha2 [5,32]. This targeted allele is termed dy-W [5]. Heterozygous Lama2dy-W/+ mice were a gift of Dr. Eva Engvall (Burnham Institute, La Jolla CA). Breeding of these heterozygotes in our laboratory was used to obtain homozygous, laminin-alpha2-null (Lama2 -/-) progeny, as well as heterozygous (Lama2+/-) and normal (Lama2+/+) littermates. Littermates were genotyped by analysis of the Lama2dy-W targeted mutation and the wild-type allele by PCR of DNA obtained from tail biopsies as described [5]. Muscles from normal littermates served as controls for Lama2-/- muscles. The Lama2dy-W/dy-W homozygotes express only very small amounts of a truncated laminin-alpha2 that lacks domain VI [6], and they have a severe neuromuscular disease in which about most mice die by 6 weeks of age [32]. All animal experiments were reviewed and approved by the Institutional Animal Care and Use Committee at the Boston Biomedical Research Institute.
###end p 18
###begin title 19
Muscle cell isolation and fluorescence-activated cell sorting
###end title 19
###begin p 20
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 32 36 32 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 60 64 60 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 748 754 <span type="species:ncbi:9913">bovine</span>
###xml 1418 1424 <span type="species:ncbi:9913">bovine</span>
To prepare cells for FACS, Lama2-/- (n = 3 at 3 weeks old), mdx (n = 2 at 4 weeks old or n = 3 at 7.5 week old), and the appropriate normal control mice (n = 2 for 4 week old controls and n = 3 for 3 week and 7.5 week old controls) were injected intra-peritoneally with 100 mul of 5-bromo-2'-deoxyuridine (BrdU) (BrdU Flow Kit, BD Biosciences) solution (1 mg/ml in PBS) at 24 hours and again at 16 hours before sacrifice. Limb muscles were dissected, cleaned, and thoroughly minced. The tissue was digested in 0.2% Pronase (Calbiochem) in HBSS at 37degreesC for one hour and successively passed through nylon mesh filters with cut-offs of 100 mum, 40 mum, and 10 mum. After the final filtering, cells were re-suspended in 3% heat-inactivated fetal bovine serum in PBS. Biotinylated Sca-1 antibody (E13-161.7) and phycoerythrin (PE)-conjugated CD45 antibody (clone 30-F11) (both from Pharmingen, San Diego CA) were added to the cells at a concentration of 2 mug/ml, and the cells were incubated on ice for one hour. Cells were washed in PBS and incubated with the secondary detecting reagent, allophycocyanin (APC)-streptavidin, at 1 mug/ml for 20 minutes on ice. After three additional washes in PBS, the cells were fixed for 30 minutes with a DPBS buffer containing 4% paraformaldehyde and the detergent saponin, then washed and stored overnight in staining buffer (from the BrdU flow kit) supplemented with 3% fetal bovine serum.
###end p 20
###begin p 21
###xml 849 857 841 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
The following day, cells were refixed as above, treated with 300 mug /ml DNase for one hour at 37degreesC, incubated for 20 minutes with fluorescein isothiocyanate (FITC) conjugated anti-BrdU antibody at a 1:50 dilution of the stock solution provided with the kit, and stained with 20 mul of a DNA binding dye, 7-amino-actinomycinD (7-AAD) (BrdU flow kit) for 1 hour. Separate aliquots of cells were stained with appropriate isotype control antibodies and used as negative controls. Flow cytometric analysis was performed using a dual-laser cell sorter (FACSCalibur, BD Biosciences) to determine the distribution and proliferation dynamics of the muscle-derived cells. Cell Quest Pro software (BD Biosciences) was used for data acquisition and analysis. Debris was first gated out by analyzing particle morphology based on side and forward scatter. In vivo proliferation was determined by analyzing the percent of all the cells that incorporated BrdU. Also, we determined the percent of cells within each sub-population that were BrdU positive.
###end p 21
###begin title 22
Statistical analyses
###end title 22
###begin p 23
###xml 408 410 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
All data are expressed as mean +/- standard deviation. Comparison among groups was done by analysis of variance (ANOVA) and individual differences between pairs was determined by unpaired two-tailed t-test performed with the Instat program (v2.03, GraphPad, San Diego CA). Statistical analyses were done either using raw data (prior to conversion to percentages) or using arcsin-transformed percentage data [33]. Differences among the disease groups or between diseased and normal controls was considered significant when p </= 0.05.
###end p 23
###begin title 24
Results
###end title 24
###begin p 25
###xml 381 382 381 382 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 387 388 387 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 395 396 395 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 401 402 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 409 410 409 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 415 417 415 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 426 427 426 427 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 432 433 432 433 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 483 487 483 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 582 587 582 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 587 591 587 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 704 706 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 746 751 746 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 751 755 751 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
###xml 755 759 <span type="species:ncbi:10090">mice</span>
We used FACS analysis to identify subsets of the mononucleate cells that reside in skeletal muscle and then determined how the distribution of cells across the subsets was affected by disease. We identified the cell subsets based on expression or lack of expression of two cell surface markers: CD45 and Sca-1. Thus, we partitioned the muscle-derived cells into four subsets: Sca-1+/CD45+, Sca-1+/CD45-, Sca-1-/Cd45+ and Sca-1-/CD45-. Cells for sorting were obtained from muscles of mdx mice and their 10ScSn normal controls at 4 weeks and 7.5 weeks after birth and from muscles of Lama2-/- and normal littermates at 3 weeks after birth. The respective myopathies are well in progress at these times [31,32]. It was not possible to analyze older Lama2-/- mice for Sca-1 and CD45 expression, as most died by 5-6 weeks of age and the small muscles did not consistently provide sufficient cells for the necessary FACS analyses.
###end p 25
###begin p 26
###xml 127 131 127 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 168 171 168 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 244 245 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 250 251 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 259 260 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 391 393 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 488 489 488 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 494 495 494 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 718 719 718 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1447 1449 1447 1449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
We found that cells from muscles of the two types of normal control mice that we used (C57Bl/10ScSn at 4 and 7.5 weeks old for mdx and C57BL/6 at 3 weeks old for Lama 2-/-) had similar distributions of cells across the four cell subsets (Figs. 1 and 2; Table 1). In all healthy muscles, the majority (>75% of the total) of mononucleate cells were negative for both Sca-1 and CD45. As noted [20], satellite cells and their myoblast progeny form multinucleate myotubes in culture, are Sca-1-/CD45-, and thus are included in this double-negative subset. We confirmed this result, because we found that (i) the double-negative cells at the time of isolation also expressed CD34, as expected for quiescent satellite cells [2]; (ii) >98% of the double-negative cells expressed desmin, an intermediate filament protein found in proliferating satellite cells, after 3 days in culture; and (iii) the double-negative cells were able to form myotubes in culture when switched to low serum medium (not shown). The rarest mononucleate cells (<1.5% of the total) in healthy muscles were those that expressed both Sca-1 and CD45. The remaining two cell subsets were more abundant than the double-positive cells, but still much less abundant than the double-negative cells. Cells that expressed Sca-1 but not CD45 amounted to 2.5 - 12% of the total in healthy muscles; and cells that expressed CD45 but not Sca-1 amounted to 4.7 - 8.3% of the total. The two Sca-1+ subsets were more abundant in the 3 and 4 week old than in the 7.5 week old healthy muscles.
###end p 26
###begin p 27
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 58 62 58 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 165 170 165 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 170 174 170 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 188 192 188 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 305 306 305 306 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 463 467 463 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 484 485 484 485 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 593 598 593 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 598 602 598 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 825 829 825 829 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 908 913 908 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 913 917 913 917 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 245 249 <span type="species:ncbi:10090">mice</span>
The composition of mononucleate cells was altered in Lama2-/- and mdx diseased muscles compared to healthy muscles. Mononucleate cells were prepared from muscles of Lama2-/- (3 week old), mdx (7.5 weeks old), and age- and strain-matched control mice and analyzed by FACS for expression of Sca-1 and CD45. A. Scatter-plots of a representative FACS study of the different cell subsets defined by Sca-1 and CD45 expression patterns in normal C57BL/10ScSn (left) and mdx (right) muscles. B. Scatter-plots of a representative FACS study of the different cell subsets in normal C57BL/6J (right) and Lama2-/- (left) muscles. Significant differences were observed in the distribution of cells between the wild type and disease conditions (see Fig. 2 and Table 1 for quantitative and statistical analyses). As also noted in the text, mdx muscles contained several-fold more mononucleate cells per gram of tissue than Lama2-/- muscles.
###end p 27
###begin p 28
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 70 75 70 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 75 79 75 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 176 180 176 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 334 335 334 335 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 419 423 419 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 501 503 501 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 538 542 538 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 588 589 588 589 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 605 610 605 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 610 614 610 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 662 664 662 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 795 799 795 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 878 883 878 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 883 887 883 887 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
The composition of mononucleate cells was altered in diseased mdx and Lama2-/- compared to control muscles. As in Fig. 1, mononucleate cells were prepared from muscles of Lama2-/- (3 week old), mdx (4 weeks or 7.5 weeks old), and appropriate age- and strain-matched control mice and analyzed by FACS for expression of Sca-1 and CD45. A. Quantitative analysis of the cell subsets defined by Sca-1 and CD45 expression in mdx and normal control muscles showed that the percentage of cells in the two CD45+ subsets was signficantly higher in mdx muscles at both 4 weeks and 7.5 weeks of age. B. Similarly, in Lama2-/- muscles, the percentage of cells in the two CD45+ subsets was also significantly higher than in normal healthy muscle. See text for statistical analyses. As also noted in the text, mdx muscles contained several-fold more mononucleate cells per gram of tissue than Lama2-/- muscles. Error bars represent standard deviation with n = 3. * indicates that diseased and healthy control samples are significantly different at p < 0.05 (see Table 1 for quantitative and statistical analyses).
###end p 28
###begin p 29
Patterns of expression of Sca-1 and CD45 by mononucleate cells derived from healthy and diseased skeletal muscles.
###end p 29
###begin p 30
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1</sup>
1Data are presented as ave. +/- SD with n = 3 for all except 4 week old values where n = 2.
###end p 30
###begin p 31
Unpaired, two-tailed t-tests (see Methods) were used to compare values from each pair of healthy and diseased muscles that were of the same age and expression pattern. P values are shown below the pair of tested values. P </= 0.05 was considered significant and indicated by an asterisk.
###end p 31
###begin p 32
###xml 230 232 226 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 252 253 248 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 258 259 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 267 268 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 361 366 357 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 366 370 362 366 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 374 378 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
We next found that the distribution profiles of cells from dystrophin-deficient and laminin-alpha2-deficient muscles differed from those of cells from normal muscles, with the diseased muscles showing a marked increase in the CD45+ cell subsets (Figs. 1 and 2, Table 1). The changes in the percentage of cells in each subset were similar for cells derived from Lama2-/- and mdx muscles.
###end p 32
###begin p 33
###xml 56 57 56 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 63 65 63 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 182 183 182 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 391 395 389 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
In particular, the rarest subset of double-positive CD45+/Sca-1+ cells composed a significantly higher percentage of the mononucleate cells in diseased muscles (Figs. 1 and 2; Table 1). The percentage of double-positive cells was increased 3-5X in diseased compared to healthy muscles. As one example, the double-positive cells amounted to 3.3 +/- 0.4% of the total cells from diseased Lama2-/- muscles, but only 1 +/- 0.4% of the cells from healthy C57BL/6 muscles (n = 3, P < 0.03).
###end p 33
###begin p 34
###xml 18 20 18 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 256 257 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 262 263 262 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 271 272 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 299 300 299 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 305 307 305 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 450 454 450 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 494 495 494 495 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 500 502 500 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 574 578 572 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 586 588 584 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 794 796 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 797 799 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 813 814 809 810 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 819 821 815 817 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 871 875 867 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e. g</italic>
###xml 957 958 953 954 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 963 964 959 960 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1096 1098 1088 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1099 1101 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1102 1104 1094 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 1105 1107 1097 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 1255 1257 1243 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1258 1260 1246 1248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1352 1354 1340 1342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1534 1535 1522 1523 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1540 1542 1528 1530 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1581 1582 1569 1570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1587 1588 1575 1576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 1596 1597 1584 1585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
The subset of CD45+ cells that did not express Sca-1, which was moderately abundant in healthy muscle and includes inflammatory cells, also accounted for a higher percentage of the total mononucleate cells in diseased muscles than in normal muscles (Figs. 1 and 2; Table 1). In particular, the Sca-1-/CD45+ cells accounted for a 5 - 8X higher percentage of the mononucleate cells in diseased than in healthy muscles. As one example, the 7.5 week old mdx muscles had a 5.7-fold increase in Sca-1-/CD45+ cells compared to healthy control muscle (28.9 +/- 3.6% of the cells in mdx samples vs. 5.1 +/- 0.2% in control muscles; n = 3, P < 0.01). These increased percentages reflect the increased numbers of inflammatory cells that are known to occur in the skeletal muscles of these disease models [21-27]. These Sca-1-/CD45+ inflammatory cells are known to be heterogeneous (e. g., macrophages, eosinophils, neutrophils, B-cells, T-cells; all of which are Sca-1-/CD45+); and the subsets of inflammatory cells that are present differ between dystrophin-deficient and laminin-alpha2-deficient muscles [21-27,29,30]. Because these different subsets of inflammatory cells have been well-characterized in dystrophin-deficient and laminin-alpha2-deficient muscles [21-27], we did not re-examine this heterogeneity for this study. The increased percentage of CD45+ cells in diseased muscles was accompanied by a significantly decreased percentage of cells in the most abundant double-negative subset, whereas the percentage of cells in the Sca-1+/CD45- subset was unchanged by disease (Figs. 1 and 2, Table 1).
###end p 34
###begin p 35
###xml 350 351 346 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 356 358 352 354 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 421 425 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 577 582 573 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 582 586 578 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 671 675 667 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 741 743 735 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 856 860 850 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 905 907 897 899 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 1020 1025 1010 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 1025 1029 1015 1019 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1075 1077 1063 1065 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 1152 1154 1138 1140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 1188 1193 1174 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 1193 1197 1179 1183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1279 1281 1263 1265 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 687 691 <span type="species:ncbi:10090">mice</span>
###xml 1041 1045 <span type="species:ncbi:10090">mice</span>
Thus, in both dystrophin-deficient and laminin-alpha2-deficient diseased muscles, the double negative cells, which included satellite cells and their myoblast progeny, became relatively less abundant, whereas cells expressing the hematopoietic marker CD45 became relatively more abundant. As in previous studies, however, the absolute number of Sca-1-/CD45- cells (muscle precursor cells) obtained from a given amount of mdx muscle was considerably larger than the number obtained from the same amount of control muscle, whereas fewer muscle precursor cells were obtained from Lama2-/- than control muscles. For example, in one experiment using muscles from 5-6 week old mdx and control mice, healthy control muscles yielded 1.3 +/- 0.4 x 105 double-negative cells per gram (the number of cells that can be obtained decreases with increasing age), whereas mdx muscles yielded many more at 4.8 +/- 3.0 x 105 double-negative cells per gram (ave. +/- SD, n = 4). In contrast, in an experiment using muscles from 3 week old Lama2-/- and control mice, we obtained 2.6 +/- 0.6 x 105 double-negative cells per gram of control muscle, but only 1.6 +/- 0.3 x 105 double-negative cells per gram of Lama2-/- muscle (ave. +/- SD, n = 3). Thus, the similar increases in the percentage of CD45+ cells in the two diseases occurred despite the different directions of change in total cell numbers.
###end p 35
###begin p 36
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 25 29 25 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 69 71 69 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 220 225 220 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 225 229 225 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 583 587 583 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 633 635 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 641 645 641 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 768 776 768 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 936 938 932 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 999 1003 995 999 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 1067 1071 1063 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 1221 1222 1217 1218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1227 1229 1223 1225 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 1283 1287 1279 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 1320 1322 1316 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
Though both mdx and Lama2-/- muscles showed similar increases in CD45+ cells, the two diseases showed opposite changes in mononucleate cell proliferation. In muscles of the two control strains (C57Bl/6J, the control for Lama2-/- muscles; and C57BL/10ScSn, the control for mdx muscles), there was a similar several-fold decrease in BrdU incorporation from 3-4 weeks to 7.5 weeks after birth, which is consistent with the slowing of muscle growth found during this postweaning period (Fig. 3A). At both 4 weeks and 7.5 weeks after birth, BrdU incorporation was significantly higher in mdx than in control muscles of the same age (Fig. 3B). In mdx muscles at 7.5 weeks after birth, for example, the percentage of all mononucleate cells that incorporated BrdU during 24 h in vivo was 6.9 +/- 2.6%, which was significantly higher than 1.9 +/- 1.1% that incorporated BrdU in the 10ScSn control muscles of the same age (n = 3, p < 0.05) (Fig. 3B). Consistent with this general increase of proliferation in mdx muscles, three of the four Sca-1/CD45 subsets of muscle-derived mdx cells showed increased BrdU incorporation, indicating a greater number of proliferating cells compared to normal controls. The exception was the Sca-1-/CD45+ cell subset which had decreased BrdU incorporation in mdx compared to normal muscles (Fig. 4A).
###end p 36
###begin p 37
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 98 102 98 102 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 125 129 125 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 170 171 170 171 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 375 380 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 380 384 380 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 427 431 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 626 627 626 627 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 718 723 718 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 723 727 723 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 896 900 896 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
The percentage of cells that incorporated BrdU decreased with increased age and was lower in Lama2-/- muscles, but higher in mdx muscles, than in normal control muscles. A. The percentage of the total population of mononucleate muscle cells that incorporated BrdU was decreased as postnatal development proceeded. In muscles of two control strains (C57Bl/6J, the control for Lama2-/- muscles; and C57BL/10ScSn, the control for mdx muscles), there was a similar several-fold decrease in BrdU incorporation from 3-4 weeks to 7.5 weeks after birth, which is consistent with the slowing of muscle growth found during this period. B. The percentage of all cells that incorporated BrdU was significantly lower in 3 week old Lama2-/- muscles than in normal control muscles of the same age. In contrast, the percentage of all that incorporated BrdU was signifcantly higher in 4 week old and 7.5 week old mdx muscles than in normal control muscles of the same age. Error bars represent standard deviation with n = 3. * indicates diseased and healthy control samples differ significantly at P < 0.05.
###end p 37
###begin p 38
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 87 91 87 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 160 161 160 161 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 195 196 195 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 201 202 201 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 263 271 263 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 302 306 302 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 364 367 364 367 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B. </bold>
###xml 417 422 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 422 426 422 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 507 512 507 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 512 516 512 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 574 575 574 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 580 582 580 582 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 769 773 769 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 776 781 776 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 781 785 781 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
In most cell subsets, the percentage of cells that incorporated BrdU was lower in Lama2-/- muscles, but higher in mdx muscles, than in healthy control muscles. A. In all cell subsets except Sca-1-/CD45+, the percentage of cells that incorporated BrdU during 24 h in vivo was significantly increased in mdx cells compared to normal cells (see text for statistics). B. The percentage of cells that incorporated BrdU in Lama2-/- muscles was significantly decreased compared to normal muscles in all subsets of Lama2-/- cells with the exception of the rare double-positive Sca-1+/CD45+ subset in which incoporation was similar in diseased and healthy muscles (see text for statistics). Error bars represent standard deviation with n = 3. * indicates that the value for the mdx or Lama2-/- muscles differed significantly from the corresponding control at P < 0.05.
###end p 38
###begin p 39
###xml 91 96 91 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 96 100 96 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 157 162 155 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 162 165 160 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 165 167 163 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 321 326 317 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 326 330 322 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 444 446 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 505 506 501 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 511 513 507 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 580 585 576 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 585 589 581 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 624 626 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
In contrast, at 3 weeks after birth, a much lower percentage of cells incorporated BrdU in Lama2-/- muscle than in normal muscle (Fig. 3B) (6.8 +/- 1.7% for Lama2-/-vs. 23.5 +/- 10.0% for normal. n = 3, p < 0.05). Consistent with this general decrease in proliferation, three of four Sca-1/CD45 subsets of muscle-derived Lama2-/- cells showed decreased BrdU incorporation, indicating fewer proliferating cells compared to normal controls (Fig. 4B). The exception in this case was the double-positive Sca-1+/CD45+ cell subset which had approximately the same BrdU incorporation in Lama2-/- muscles as in normal muscles (Fig. 4B).
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 135 139 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 143 148 143 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 148 152 148 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 210 214 210 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 251 256 247 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 256 260 252 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 322 324 318 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 451 455 447 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 459 464 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 464 468 460 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 590 594 586 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 634 639 630 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 639 643 635 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
We found that the composition and proliferation dynamics of mononucleate cells were significantly different in the diseased muscles of mdx and Lama2-/- mice than in normal healthy muscles. Dystrophin-deficient mdx muscles and laminin-alpha2-deficient Lama2-/- muscles showed similar changes in cell compositions, with CD45+ cells accounting for a significantly higher percentage of the total in diseased than in healthy muscles. In contrast, cells in mdx and Lama2-/- muscles showed opposite changes in proliferation kinetics, with most cell subsets showing increased BrdU incorporation in mdx muscles, but decreased incorporation in Lama2-/- muscles.
###end p 41
###begin p 42
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 594 596 594 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 676 678 676 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 679 680 679 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
With the recognition that adult skeletal muscles contain rare cells with stem cell properties, a number of markers, including Sca-1, CD34, CD45, Bcl-2, and c-kit, have been used alone or in combination to identify and purify the cells [1,18,19,28,34-37]. In our study, we subdivided muscle-derived stem cells on the basis of expression or lack of expression of Sca-1, which is commonly used to purify hematopoietic stem cells, and CD45, which is a pan-hematopoietic cell marker. Neither Sca-1 nor CD45 is expressed by muscle satellite cells and their myoblast progeny (muscle precursor cells) [20], whereas muscle-derived cells with hematopoietic potential are almost all CD45+ [1,20].
###end p 42
###begin p 43
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 379 381 379 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 390 394 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i. e</italic>
###xml 402 403 402 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 408 410 408 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 426 428 426 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 434 435 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 443 444 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 472 473 472 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 478 480 478 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 548 549 548 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 569 570 569 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 575 577 575 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 659 661 659 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 725 726 725 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 731 733 731 733 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 894 895 894 895 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 900 902 900 902 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 978 982 978 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
Though the distribution of cells among the four cell subsets did not significantly change during early postnatal (3 to 7.5 weeks) development in normal muscles (compare controls in Figs. 2A and 2B), there was a significant shift in the distribution profile in response to muscle disease. Specifically, diseased muscles had a large increase in the percentage of cells in both CD45+ subsets, i. e., Sca-1+/CD45+ and Sca-1-/ CD45+ (Fig. 2, Table 1). The double-positive Sca-1+/CD45+ cells were likely putative stem cells with hematopoietic potential [1], whereas the Sca-1-/CD45+ cells included the heterogeneous group of inflammatory cells. The increase in CD45+ cells was accompanied by a decrease in the double-negative Sca-1-/CD45- cells, which included satellite cells and their myoblast progeny. Though the double-negative cells were usually the most abundant subset, we found that the Sca-1-/CD45+ inflammatory cells became the most abundant subset in younger four week old mdx muscles, which is consistent with the rapid myofiber degeneration at this age.
###end p 43
###begin p 44
###xml 50 51 50 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 56 58 56 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 271 272 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 427 431 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 455 460 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 460 464 460 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 516 517 516 517 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 522 524 522 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 629 630 629 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 631 632 631 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
A previous study showed that double-positive Sca-1+/CD45+ cells also increase during regeneration of injured muscle and that a small proportion of the double-positive cells from injured muscle, unlike those from uninjured muscles, give rise to myogenic cells in culture [3,4]. Diseased muscles tend to undergo extensive degeneration followed by attempted regeneration. At least initially, regeneration is largely successful in mdx muscles but abortive in Lama2-/- muscles [5,15,31]. Because the double-positive Sca-1+/CD45+ cells increased in both types of diseased muscle (this study), it is likely that, as in injured muscles [3,4], these cells play a role in attempted muscle regeneration.
###end p 44
###begin p 45
###xml 44 46 44 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 121 127 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama-2</italic>
###xml 127 131 127 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 180 187 180 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 221 225 221 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 250 256 250 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama-2</italic>
###xml 256 260 256 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
In contrast to the similar increases in CD45+ cells in both types of diseased muscles, the mononucleate cells in mdx and Lama-2-/- muscles showed opposite changes in proliferation in vivo, with proliferation increased in mdx muscles but decreased in Lama-2-/- muscles compared to healthy control muscles.
###end p 45
###begin p 46
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 308 312 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 518 519 518 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 524 526 524 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 580 584 580 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 648 652 648 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">e. g</italic>
###xml 725 726 725 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 731 732 731 732 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 857 858 857 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 859 861 859 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 909 913 909 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 919 927 919 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 971 975 971 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 1210 1212 1210 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1213 1215 1213 1215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
Total cell proliferation in mdx muscles was known to be elevated relative to healthy controls [31]. Here we examined proliferation in subsets of the muscle mononucleate cells and found that, consistent with the increase in overall proliferation, a higher than normal percentage of cells in three of the four mdx subsets incorporated BrdU. Both the double-negative cells, which included satellite cells, and the double-positive cells with hematopoietic potential, showed increased proliferation. Only cells of the Sca-1-/CD45+ subset failed to show increased BrdU incorporation in mdx muscles; and these were likely to be mostly inflammatory cells (e. g., macrophages, eosinophils, neutrophils, T-cells; all of which are Sca-1-/CD45+) which do not have hematopoietic stem cell potential but are known to migrate into and thus accumulate in diseased muscles [1,21-27]. The increased percentage of proliferating mdx cells in vivo is likely due to the altered environment in mdx muscles which includes increased levels of growth factors; increased extracellular matrix proteins such as collagen, fibronectin, and laminin which can promote myoblast proliferation; and perhaps decreased levels of growth inhibitors [38-42]. Whether cells in different subsets respond to the same or different growth regulators remains to be determined.
###end p 46
###begin p 47
###xml 3 8 3 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 8 12 8 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 163 168 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 168 172 168 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 221 222 221 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 227 229 227 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 355 360 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 360 364 360 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 446 447 446 447 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0</sub>
###xml 511 516 511 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 516 520 516 520 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 595 600 595 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 600 604 600 604 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 733 734 729 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
In Lama2-/- muscles, overall BrdU incorporation was significantly decreased compared to that in healthy control muscles. BrdU incorporation was decreased in every Lama2-/- cell subset except the rare double-positive Sca-1+/CD45+ subset that includes cells with hematopoietic potential [1]. The decrease could have arisen if, relative to normal cells, the Lama2-/- cells had longer cell cycles or lower probability of initiating replication from G0, if there was more cell death among dividing than non-dividing Lama2-/- cells [43], or if some combination of these occurred. The relative lack of Lama2-/- muscle cell proliferation could in part explain why regeneration is relatively unsuccessful in laminin-alpha2-deficient muscles [5], though other mechanisms such as increased apoptosis of both myoblasts and newly formed myofibers are also likely to be important.
###end p 47
###begin p 48
###xml 71 73 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 125 133 121 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 137 146 133 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 196 197 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 198 200 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 201 203 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 366 371 362 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 371 375 367 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 489 491 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 492 494 484 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 815 817 796 798 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1032 1034 1002 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
Laminin-alpha2 is expressed in skeletal muscle myoblasts and myotubes [44] where it promotes the survival of satellite cells in vivo and in vitro as well as myoblast fusion and myotube formation [5,45,46]. We found that the most abundant, double-negative subset of muscle cells, which includes muscle precursor cells, showed significantly less BrdU incorporation in Lama2-/- muscles. It is likely, therefore, that laminin-alpha2 not only promotes survival of myotubes as shown previously [45,46] but also influences division of muscle precursor cells as early as three weeks after birth, which is a time when extensive myofiber growth occurs in normal muscles. A recent study has demonstrated that laminin-2 (alpha2, beta1, gamma1) improves proliferation of an epithelial cell line through an integrin/ERK pathway [47]. A similar mechanism could occur in skeletal muscle cells, because merosin, of which laminin-alpha2 is a component, influences the level of expression and localization of alpha7beta 1D integrin at the sarcolemma [46] and a lack of laminin-alpha2 could, therefore, disrupt merosin/integrin-mediated signals that regulate proliferation.
###end p 48
###begin p 49
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 46 50 46 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 136 138 136 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 229 230 229 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 235 237 235 237 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 636 637 636 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 642 644 642 644 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 677 678 677 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1121 1123 1121 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 1164 1165 1164 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 1178 1180 1178 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 1261 1263 1261 1263 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 78 84 <span type="species:ncbi:9606">humans</span>
###xml 176 181 <span type="species:ncbi:10090">mouse</span>
Pathogenesis follows distinct courses in Lama2-/- and mdx mice, as well as in humans with corresponding diseases [48]. Nonetheless, CD45+ cells are similarly increased in both mouse diseases. The role of the double-positive Sca-1+/CD45+ cells in muscles needs to be defined, perhaps by tracing fates of their progeny; and the likely heterogeneity within the cell subsets we studied should be explored. For example, one study with a specific mAb suggested that satellite cells are <15% of the mononucleate cells in healthy, post-weaning skeletal muscles [49], suggesting that there might be heterogeneity within the double-negative Sca-1-/CD45- cell subset which we and others [3] found to contain more than half of the mononucleate cells and to contain satellite cells. Some differences between studies might be expected because assessment of cell type percentages likely depends on the particular enzymes used for tissue dissociation, the antibodies and staining protocols used, and the selection of fluorescent cut-off limits for cells sorting. Despite these caveats, the general agreement between our study of healthy vs. diseased muscles and an earlier study [3] of healthy vs. cardiotoxin-injured muscles provides confidence in the conclusion that the CD45+ cell subsets become relatively more abundant in both injured muscles and in the two types of diseased muscles analyzed here.
###end p 49
###begin p 50
###xml 311 312 311 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 317 319 317 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 536 547 536 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2-null </italic>
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 620 621 620 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 626 628 626 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 741 746 741 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 746 750 746 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 754 758 754 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 902 907 902 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 907 911 907 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 996 1001 996 1001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 1001 1005 1001 1005 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1046 1051 1046 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 1051 1055 1051 1055 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1090 1092 1090 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
Further experiments in which particular cell subsets have their fates determined by lineage tracking or are experimentally increased or decreased, perhaps by specific growth factors or conditional ablation, could determine how the changes in cell subsets that we observed here may affect pathogenesis. The Sca-1+/CD45- cell subset, for example, has been reported to contain cells with myogenic and endothelial lineage potentials [28]. Inhibition of apoptosis ameliorates myopathology and produces a several-fold increase in lifespan of Lama2-null mice [50], and could affect mononuclear cell subsets. That not only Sca-1-/CD45- cells (which included satellite cells), but also other cell subsets, showed opposite changes of proliferation in Lama2-/- and mdx muscle, suggests that growth requirements may be shared among the different subsets of cells. In addition, the relatively poor proliferation of Lama2-/- cells may be one of the mechanisms underlying the lack of successful regeneration in Lama2-/- muscles. The comparative significance to Lama2-/- pathogenesis of poor proliferation vs. other mechanisms such as increased apoptosis remains to be defined.
###end p 50
###begin title 51
Conclusion
###end title 51
###begin p 52
###xml 29 31 29 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
The similar increases in CD45+ cells, but opposite changes in proliferation of muscle precursor cells, may underlie aspects of the distinct pathologies in dystrophin-deficiency and laminin-alpha2-deficiency.
###end p 52
###begin title 53
Competing interests
###end title 53
###begin p 54
The author(s) declare that they have no competing interests.
###end p 54
###begin title 55
Authors' contributions
###end title 55
###begin p 56
MG and CAK carried out all of the experimental studies. MG and JBM conceived the study, carried out statistical analyses and drafted the manuscript.
###end p 56
###begin title 57
Pre-publication history
###end title 57
###begin p 58
The pre-publication history for this paper can be accessed here:
###end p 58
###begin p 59

###end p 59
###begin title 60
Acknowledgements
###end title 60
###begin p 61
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lama2</italic>
###xml 46 48 46 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dy</italic>
###xml 49 51 49 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">W </italic>
###xml 44 51 44 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/<italic>dy</italic>-<italic>W </italic></sup>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
We thank Dr. Eva Engvall for supplying Lama2+/dy-W mice. This work was supported by grants to J.B.M. from the Muscular Dystrophy Association, the National Institutes of Health (AR49496, ES11384, HL6464), and the United States Department of Agriculture.
###end p 61
###begin article-title 62
Muscle-derived hematopoietic stem cells are hematopoietic in origin
###end article-title 62
###begin article-title 63
Muscle satellite cells
###end article-title 63
###begin article-title 64
Wnt signaling induces the myogenic specification of resident CD45+ adult stem cells during muscle regeneration
###end article-title 64
###begin article-title 65
Pax7 Is Necessary and Sufficient for the Myogenic Specification of CD45(+):Sca1(+) Stem Cells from Injured Muscle
###end article-title 65
###begin article-title 66
Activation of the lama2 gene in muscle regeneration: abortive regeneration in laminin alpha2-deficiency
###end article-title 66
###begin article-title 67
###xml 91 95 <span type="species:ncbi:10090">mice</span>
Laminin alpha2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice
###end article-title 67
###begin article-title 68
Merosin, a protein specific for basement membranes of Schwann cells, striated muscle, and trophoblast, is expressed late in nerve and muscle
###end article-title 68
###begin article-title 69
Merosin/laminin-2 and muscular dystrophy
###end article-title 69
###begin article-title 70
Merosin-deficient congenital muscular dystrophy, autosomal recessive (MDC1A, MIM#156225 LAMA2 gene coding for alpha 2 chain of laminin)
###end article-title 70
###begin article-title 71
Pharmacological strategies for muscular dystrophy
###end article-title 71
###begin article-title 72
Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy
###end article-title 72
###begin article-title 73
Congenital muscular dystrophy with merosin deficiency
###end article-title 73
###begin article-title 74
###xml 53 57 <span type="species:ncbi:10090">mice</span>
The molecular basis of muscular dystrophy in the mdx mice : a point mutation
###end article-title 74
###begin article-title 75
###xml 28 33 <span type="species:ncbi:10090">mouse</span>
Aging normal and dystrophic mouse muscle: analysis of myogenicity in cultures of living single fibers
###end article-title 75
###begin article-title 76
Duchenne's muscular dystrophy: animal models used to investigate pathogenesis and develop therapeutic strategies
###end article-title 76
###begin article-title 77
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
Purification and characterization of mouse hematopoietic stem cells
###end article-title 77
###begin article-title 78
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
Dystrophin expression in the mdx mouse restored by stem cell transplantation
###end article-title 78
###begin article-title 79
Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing
###end article-title 79
###begin article-title 80
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice
###end article-title 80
###begin article-title 81
Myogenic specification of side population cells in skeletal muscle
###end article-title 81
###begin article-title 82
Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells
###end article-title 82
###begin article-title 83
Congenital muscular dystrophy with primary laminin alpha2 (merosin) deficiency presenting as inflammatory myopathy
###end article-title 83
###begin article-title 84
###xml 127 131 <span type="species:ncbi:10090">mice</span>
Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells
###end article-title 84
###begin article-title 85
###xml 48 53 <span type="species:ncbi:10090">mouse</span>
T-cell-dependent fibrosis in the mdx dystrophic mouse
###end article-title 85
###begin article-title 86
Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy
###end article-title 86
###begin article-title 87
###xml 112 116 <span type="species:ncbi:10090">mice</span>
Complement 3 deficiency and oral prednisolone improve strength and prolong survival of laminin alpha2-deficient mice
###end article-title 87
###begin article-title 88
Prednisolone decreases cellular adhesion molecules required for inflammatory cell infiltration in dystrophin-deficient skeletal muscle
###end article-title 88
###begin article-title 89
Identification of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle
###end article-title 89
###begin article-title 90
The leukocyte common antigen family
###end article-title 90
###begin article-title 91
The biology of hematopoietic stem cells
###end article-title 91
###begin article-title 92
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mdx </italic>
###xml 102 107 <span type="species:ncbi:10090">mouse</span>
Electron microscopic and autoradiographic characterization of hindlimb muscle regeneration in the mdx mouse
###end article-title 92
###begin article-title 93
###xml 83 88 <span type="species:ncbi:10090">mouse</span>
Merosin-deficient congenital muscular dystrophy. Partial genetic correction in two mouse models
###end article-title 93
###begin article-title 94
###xml 48 53 <span type="species:ncbi:9606">human</span>
In vitro and in vivo hematopoietic potential of human stem cells residing in muscle tissue
###end article-title 94
###begin article-title 95
Bcl-2 expression identifies an early stage of myogenesis and promotes clonal expansion of muscle cells
###end article-title 95
###begin article-title 96
Primate skeletal muscle contains cells capable of sustaining in vitro hematopoiesis
###end article-title 96
###begin article-title 97
Neuronal differentiation of stem cells isolated from adult muscle
###end article-title 97
###begin article-title 98
###xml 49 53 <span type="species:ncbi:10090">mice</span>
Characteristics of skeletal muscle in mdx mutant mice
###end article-title 98
###begin article-title 99
Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscle
###end article-title 99
###begin article-title 100
###xml 126 131 <span type="species:ncbi:10090">mouse</span>
Accumulation of collagen and altered fiber-type ratios as indicators of abnormal muscle gene expression in the mdx dystrophic mouse
###end article-title 100
###begin article-title 101
###xml 71 77 <span type="species:ncbi:10090">murine</span>
Laminin alters cell shape and stimulates motility and proliferation of murine skeletal myoblasts
###end article-title 101
###begin article-title 102
###xml 114 119 <span type="species:ncbi:10090">mouse</span>
Altered deposition of extracellular matrix components in the skeletal muscle and lymph node of the MDX dystrophic mouse
###end article-title 102
###begin article-title 103
Bcl-2-induced changes in E2F regulatory complexes reveal the potential for integrated cell cycle and cell death functions
###end article-title 103
###begin article-title 104
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo
###end article-title 104
###begin article-title 105
Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival
###end article-title 105
###begin article-title 106
Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy
###end article-title 106
###begin article-title 107
Laminin-2 stimulates the proliferation of epithelial cells in a conjunctival epithelial cell line
###end article-title 107
###begin article-title 108
Congenital muscular dystrophies
###end article-title 108
###begin article-title 109
###xml 88 94 <span type="species:ncbi:10090">murine</span>
Purification and cell-surface marker characterization of quiescent satellite cells from murine skeletal muscle by a novel monoclonal antibody
###end article-title 109
###begin article-title 110
Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy
###end article-title 110

